US Patent

US8623418 — Pharmaceutical composition

Method of Use · Assigned to Alpharma Pharmaceuticals LLC · Expires 2029-11-07 · 3y remaining

Vulnerability score 68/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a pharmaceutical composition that includes an antagonist, an agonist, a seal coat, and a sequestering polymer, used for treating pain.

USPTO Abstract

Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal coat forms a layer physically separating the antagonist from the agonist from one another. Methods for manufacturing such a pharmaceutical composition are also provided. Methods for treating pain using such compositions is also demonstrated.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-1640 chembl-chembl2103744
U-1640 chembl-chembl2103744
U-1640 chembl-chembl2103744
U-1640 chembl-chembl2103744
U-1640 chembl-chembl2103744
U-1640 chembl-chembl2103744

Patent Metadata

Patent number
US8623418
Jurisdiction
US
Classification
Method of Use
Expires
2029-11-07
Drug substance claim
No
Drug product claim
No
Assignee
Alpharma Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.